Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus

Published:2017-10-05 Issue:10 Volume:12 Page:e0185459
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mantovani Alessandro,Rigolon Riccardo,Pichiri Isabella,Bonapace Stefano,Morani Giovanni,Zoppini Giacomo,Bonora Enzo,Targher Giovanni^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Global epidemiology of nonalcoholic fatty liver disease—Meta-analytic assessment of prevalence, incidence, and outcomes;ZM Younossi;Hepatology,2016

2. Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups;A Lonardo;Dig Liver Dis,2015

3. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extra-hepatic diseases;LA Adams;Gut,2017

4. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease;G Targher;N Engl J Med,2010

5. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis;G Targher;J Hepatol,2016

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study;Cardiovascular Diabetology;2024-08-27

2. Cardiac abnormalities pre- and post-liver transplantation for metabolic dysfunction-associated steatohepatitis – Evidence and special considerations;Journal of Liver Transplantation;2024-08

3. Electrocardiographic abnormalities in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis;Current Problems in Cardiology;2024-07

4. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With an Increased Risk of Congestive Heart Failure in Hospitalized Patients With Cirrhosis: A Propensity Score-Matched Analysis;Cureus;2024-06-15

5. Metabolic dysfunction-associated steatotic liver disease and the risk of mortality in individuals with type 2 diabetes: a systematic review and meta-analysis;European Journal of Gastroenterology & Hepatology;2024-02-23